Skip to main content

Fatigue and Kampo (Japanese Herbal) Medicines: Hochuekkito and Juzentaihoto

  • Protocol
  • First Online:
Herbal Medicines

Part of the book series: Methods in Pharmacology and Toxicology ((MIPT))

  • 979 Accesses

Abstract

Together with pain and fever, fatigue is known as one of the living body’s three main alarms, an important signal to the body for the maintenance of life and health. The body usually recovers from fatigue with rest, but a feeling of fatigue may persist for a long period. When the symptoms and duration of fatigue exceed the usual fatigued feeling, the body’s immune function deteriorates making it prone to psychological disorders such as depression, as well as a range of infectious diseases. Few Western medications are useful for this kind of fatigue. There are, however, many useful formulae among Kampo medications. The introduction below first gives a brief explanation of qi (Ki), blood and fluid (Kiketsusui), and the “patterns” of Kampo medical diagnosis before discussing the Kampo medical diagnoses “qi (Ki) deficiency (Kikyo), blood deficiency (Kekkyo), and dual deficiency of qi (Ki) and blood (Kiketsu Ryokyo)” and how fatigue was perceived in olden times. The “Discussion” part focuses on clinical reports on two prominent Kampo medications, hochuekkito (補中益気湯) and juzentaihoto (十全大補湯).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Yamakawa J (2012) Efficacy evaluation of kampo medicine in a mouse model of chronic fatigue syndrome. In: Motoo Y (ed) Traditional medicine new research. Nova Science Publishers, Inc, New York, pp 83–122

    Google Scholar 

  2. Chen R, Moriya J, Yamakawa J et al (2010) Traditional Chinese medicine for chronic fatigue syndrome. Evid Based Complement Alternat Med 7:3–10

    Article  PubMed  Google Scholar 

  3. Otsuka K, Otsuka Y, Watanabe K (2000) Practical symptom-based kampo therapy (Revised), 5th edn. Nanzando, Tokyo, pp 231–232

    Google Scholar 

  4. Matsuda K (1992) Practice of kampo treatment – diagnosis and treatment, 74(11). Shindan To Chiryo Sha Inc, Osaka, pp 2278–2282

    Google Scholar 

  5. Tatsuno K (1979) An outline of kampo medicine 1 (1). Yukonsha, Kyoto, pp 12–14

    Google Scholar 

  6. Terasawa K (2005) Kampo patterns (Sho): a patient-centered, not disease-centered, diagnostic system. Kagaku 75. Iwanami Shoten Publishers, Tokyo, pp 821–823

    Google Scholar 

  7. Matsuda K (1980) “Yoshimasu Nangai”, an exposition of his compendium, vol 37. Meicho Shuppan, Osaka, p 16

    Google Scholar 

  8. Yoshimasu N Medical Patterns – Modern Kampo Medicine Compendium vol 37 p 134

    Google Scholar 

  9. Terasawa K (2006) On the formation of Chinese great classic “shokanron”, and its specificity. Kampo Med 57:799–804

    Article  Google Scholar 

  10. The Japan Kampo Medicine Association – Academic Committee (2000) Shanhan Zabinglun (Treatise on Cold Damage Disorders), 3rd edn. Toyo Gakujutsu Shuppansha, Chiba

    Google Scholar 

  11. Mayanagi M (1989) A bibliographical introduction to Neiwaishangbianhuolun (Treatise on clarification of perplexities about internal and external damage), Piweilun (Treatise on the spleen and stomach), and Lanshimicang (Secret records of the orchid chamber), Kosoto H, Mayanagi M (eds). Wakoku Kanseki Isho Shusei vol 6 Commentary. Enterprise, Tokyo, p 22–36

    Google Scholar 

  12. Mayanagi M, Kosoto H (1990) Medical texts in Jin period. J Tradit Sino-Jpn Med 11:495–501

    Google Scholar 

  13. Mayanagi M (1995) The history of a Chinese herbal prescription Bu-Zhong-Yi-Qi-Tang. J Tradit Sino-Jpn Med 16:501–507

    Google Scholar 

  14. Yamakawa J, Motoo Y, Moriya J et al (2013) Role of kampo medicine in integrative cancer therapy. Evid Based Complement Alternat Med 2013:570848

    PubMed  PubMed Central  Google Scholar 

  15. Yamakawa J, Motoo Y, Moriya J et al (2013) Significance of Kampo, traditional Japanese medicine, in supportive care of cancer patients. Evid Based Complement Alternat Med 2013:746486

    PubMed  PubMed Central  Google Scholar 

  16. Yamakawa J, Moriya J, Takeuchi K et al (2013) Significance of Kampo, Japanese traditional medicine, in the treatment of obesity: basic and clinical evidence. Evid Based Complement Alternat Med 2013:943075

    PubMed  PubMed Central  Google Scholar 

  17. Yamakawa J, Moriya J, Takahashi T et al (2010) A Kampo medicine, Boi-ogi-to, inhibits obesity in ovariectomized rats. Evid Based Complement Alternat Med 7:87–95

    Article  PubMed  Google Scholar 

  18. Abe K (1989) The effects of hochuekkito for side effects of chemotherapy after cancer surgery. Prog Med 9:2916–2922

    Google Scholar 

  19. Ohara T, Onda M, Futagawa S et al (1993) Study of the usefulness of combining hochuekkito and ninjinyoeito with Tegafur. Jpn Pharmacol Ther 21:4423–4434

    Google Scholar 

  20. Ohno S (1988) Effects of a traditional Chinese medicine “hochuekki-to” on natural killer activity. Arerugi 37:107–114

    Google Scholar 

  21. Watanabe A, Hasegawa S (1992) Effect of combined Kampo medicines as adjuvant therapy for pulmonary tuberculosis. Jpn Med J 3553:76–77

    Google Scholar 

  22. Suzuki J, Arata S, Sugiyama M (2002) Improvement of immunity and nutrition by hochuekkito in immune-compromised hosts–for the control of MRSA. Prog Med 22:1362–1363

    Google Scholar 

  23. Irie K, Tateishi M, Yuu H et al (1992) Clinical effects of hochuekkito on gastroptosis symptoms. J N Remedies Clin 41:423–432

    Google Scholar 

  24. Tomita H, Chiba S, Kadowaki J et al (1997) Clinical effects of hochuekkito on pediatric orthostatic disturbance. J Pediatr Pract 60:162–167

    Google Scholar 

  25. Kuratsune H, Yamaguchi K, Tokumine Y (1997) Kampo formulations for chronic fatigue syndrome–clinical effects of hochuekkito. Jpn J Clin Exp Med 74:1837–1845

    Google Scholar 

  26. Kuratsune H, Nakatomi Y, Kagura M et al (2010) Clinical effectiveness of twice daily hochuekkito for chronic fatigue syndrome patients. Prog Med 30:505–510

    Google Scholar 

  27. Moriya J (2006) Establishment of murine model for chronic fatigue syndrome and efficacy of kampo medicine on daily activity. J Kanazawa Med Univ 31:263–268

    Google Scholar 

  28. Chen R, Moriya J, Yamakawa J et al (2008) Brain atrophy in a murine model of chronic fatigue syndrome and beneficial effect of Hochu-ekki-to (TJ-41). Neurochem Res 33:1759–1767

    Article  CAS  PubMed  Google Scholar 

  29. Matsuzawa K, Nakano H, Oonishi Y (1997) Effects of hochuekkito for sleep-disordered breathing―a preliminary study using pulse oximetry. Jpn J Chest Dis 56:846–849

    Google Scholar 

  30. Ping L, Takase K, Mukobayashi M et al (1996) Clinical effects of traditional Chinese herbal medicine “Hochuekkito” on male infertility. Advances Obstet Gynecol 48:406–410

    Google Scholar 

  31. Ohara K, Nishimoto M, Miyazato K et al (1994) Effects of hochuekkito (TJ-41) for anorexia. Prog Med 14:1705–1712

    Google Scholar 

  32. Kurokawa T, Imai J, Tamakuma M (1989) Improvement of anorexia, nausea and vomiting, and lassitude, side effects of anti-cancer drug administration. “Effects of juzentaihoto in preventing anti-cancer drug side effects–A clinical immunology study”. Biotherapy 3:789–795

    Google Scholar 

  33. Suzuki S, Abe R, Nomizu T et al (1995) Effect of juzentaihoto (TJ-48) on leukopenia in patients receiving cancer chemotherapy. Prog Med 15:1968–1971

    Google Scholar 

  34. Niwa K, Hashimoto M, Tamaya T (2000) Effects of Juzen-taiho-to and M-CSF on thrombocytopenia induced by anti-cancer drugs in gynecologic malignancies. Jpn J Orient Med 51:447–454

    Google Scholar 

  35. Yamada T (1992) Clinical study of juzen-taiho-to administration for postoperative esophageal carcinoma, gastric carcinoma, and colorectal carcinoma – Influence of surgical intervention and postoperative chemotherapy on cell mediated immunity. J Med Pharm Soc WAKAN-YAKU 9:157–164

    Google Scholar 

  36. Rino Y, Yukawa N, Yamada R et al (2013) Improvement of adverse effects by juzen-taiho-to in the chemotherapy for patients with advanced or recurrent gastric cancer. J Jpn Coll Surg 38:62–66

    Google Scholar 

  37. Konno H, Maruo Y, Baba S et al (1997) Improvement of immunocompetence with combined use of juzendaihoto in adjuvant chemotherapy after gastric cancer surgery. Biotherapy 11:193–199

    Google Scholar 

  38. Kosaka A, Kamiya T, Sumiyama M et al (1994) Usefulness of TSUMURA Juzentaihoto (TJ-48) for reducing adverse effects of anticancer drugs and improving QOL. Prog Med 14:2259–2264

    Google Scholar 

  39. Adachi I (1990) Supporting therapy with Shi Quan Da Bu Tang in advanced breast cancer patients. Biomed Res 11:25–31

    Google Scholar 

  40. Tanaka Y, Hashimoto S (1988) Effects of TSUMURA Juzentaihoto on various complaints occurring as adverse reactions during radiotherapy. JAMA 6:70–71

    Google Scholar 

  41. Tarao K, Okamoto T, Miyakawa K et al (2003) Effect of Juzen-taiho-to on the serum alanine aminotransferase levels in patients with HCV-associated chronic hepatitis or liver cirrhosis. Jpn J Orient Med 54:191–198

    Google Scholar 

  42. Tarao K, Sakamoto Y, Ueno M et al (2010) Juzentaihoto (TJ-48) may be an important and effective anti-inflammatory agent for intractable cases of patients with HCV-associated chronic liver-diseases. Jpn J Orient Med 61:1–8

    Google Scholar 

  43. Sho Y, Fujisaki K, Sakashita H et al (2004) Orally administered Kampo medicine, Juzen-taiho-to, ameliorates anemia during interferon plus ribavirin therapy in patients with chronic hepatitis C. J Gastroenterol 39:1202–1204

    Article  CAS  PubMed  Google Scholar 

  44. Higuchi K, Shimizu Y, Yasumura S et al (2002) Preventive effect of liver carcinogenesis by juzen-taiho-to in the patients with liver cirrhosis. Kan-Tan-Sui 44:341–346

    Google Scholar 

  45. Aoe H, Ota M, Kawahara N et al (2003) Efficacy of using juzentaihoto to augment preoperative autologous blood donation. J Med Technol 47:395–399

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jun-ichi Yamakawa .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this protocol

Cite this protocol

Yamakawa, Ji., Moriya, J., Kobayashi, J. (2016). Fatigue and Kampo (Japanese Herbal) Medicines: Hochuekkito and Juzentaihoto. In: Inui, A. (eds) Herbal Medicines. Methods in Pharmacology and Toxicology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-4002-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-4002-8_8

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-4000-4

  • Online ISBN: 978-1-4939-4002-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics